Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific’s FilterWire EZ

This article was originally published in The Gray Sheet

Executive Summary

Embolic protection system gains expanded FDA market clearance for use in carotid artery stenting procedures. Previously approved for use in coronary saphenous vein graft interventions in 2004, FilterWire EZ is intended for use with Boston Scientific's NexStent for carotid artery stenting. NexStent gained PMA approval Oct. 27 for carotid artery stenting with the Monorail delivery system (1"The Gray Sheet" Nov. 13, 2006, In Brief). Already approved carotid artery stents with embolic protection systems include Abbott's Acculink stent with Accunet and its Xact stent with Emboshield, as well as Johnson & Johnson/Cordis' Precise stent with AngioGuard. Medtronic expects FDA approval in late 2007 for its Exponent carotid stent with the GuardWire system...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel